Double Delegate Pass – European RWE & Market Access Summit 2026 (Amsterdam)

Master the New Era of EU Joint Clinical Assessments (JCA) Together

As the pharmaceutical industry faces the structural shifts of the new European Health Technology Assessment (HTA) regulations, cross-functional alignment is no longer optional, it is a critical launch requirement. The European RWE & Market Access Summit 2026 is the definitive gathering for HEOR, Medical Affairs, and Market Access leaders navigating the complexities of JCA submissions and PICO planning.

Don’t navigate these regulatory hurdles in isolation. Our Double Delegate Pass is strategically designed for pharmaceutical and biotech organizations to send two key stakeholders, ensuring your clinical evidence and commercial strategies are completely synchronized

NOTE: This Pass is not valid for Solution Providers, Services Providers or Consultants.

What Your Double Delegate Pass Unlocks (2 Entries):

This premium dual-entry pass grants both delegates unrestricted access to all core strategic pillars of the summit:

• EU HTA & JCA Strategy: Learn directly from pioneers who are actively shaping and submitting early Joint Clinical Assessments.

• Evidence to Access: Discover how to effectively map real-world evidence (RWE) pipelines directly into early Phase II and III clinical trial designs.

• Elite Networking: Connect face-to-face with Europe’s leading HTA authorities, payers, and pharma executives during dedicated collaborative sessions.

• Value & Pricing: Master the cross-over strategies between centralized JCA evaluations and local, country-level budget impact assessments.

Value Buy: Save 50% on Your Corporate Registration

Streamline your corporate professional development budget while multiplying your team’s strategic takeaways.

• Standard Individual Price: 2,399 for separate registrations.

• Double Delegate Value Package: Buy together and unlock a 50% discount, reducing the investment to just 1,199 per ticket (Billed as a flat 2,398 at checkout).

Pass Inclusion Details (Per Delegate):

• Full access to all keynote presentations, panel tracks, and interactive JCA workshops across October 21-22, 2026.

• Entry into all official networking luncheons, reception spaces, and exhibition areas.

• Post-event access to downloadable summit slide decks, whitepapers, and presentation recordings.

• Direct access to the event’s networking & B2B meetings.

Secure your organization’s competitive edge in the evolving European market access landscape. Select quantity “1” to purchase this 2-entry package.

Who Should Utilize the Team Pass?

This pass is ideal for high-level technical and commercial teams from Pharma, Biotech, and Digital Health:

• VPs & Directors of Market Access and HEOR

• Global Leads for RWE and Evidence Strategy

• Pricing & Reimbursement Decision Makers

• Regulatory Strategy and Medical Affairs Teams